BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 157126)

  • 1. Axillofemoral arterial bypass grafts.
    Devine TJ; Myers KA; Scott DF
    Aust N Z J Surg; 1979 Apr; 49(2):215-8. PubMed ID: 157126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillofemoral bypass: a critical reappraisal of its role in the management of aortoiliac occlusive disease.
    Ray LI; O'Connor JB; Davis CC; Hall DG; Mansfield PB; Rittenhouse EA; Smith JC; Wood SJ; Sauvage LR
    Am J Surg; 1979 Jul; 138(1):117-28. PubMed ID: 157077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic arterial grafts. III. The outcome in 22 patients with synthetic axillofemoral bypass grafts.
    Christenson JT; Einarsson E; Eklöf B; Norgren L
    Scand J Thorac Cardiovasc Surg; 1978; 12(2):121-4. PubMed ID: 152457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillofemoral bypass with externally supported, knitted Dacron grafts: a follow-up through twelve years.
    el-Massry S; Saad E; Sauvage LR; Zammit M; Davis CC; Smith JC; Rittenhouse EA; Fisher LD
    J Vasc Surg; 1993 Jan; 17(1):107-14; discussion 114-5. PubMed ID: 8421326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions. Veterans Affairs Cooperative Study #141.
    Johnson WC; Lee KK
    J Vasc Surg; 1999 Dec; 30(6):1077-83. PubMed ID: 10587392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillofemoral bypass: a ten-year review.
    Burrell MJ; Wheeler JR; Gregory RT; Synder SO; Gayle RG; Mason MS
    Ann Surg; 1982 Jun; 195(6):796-9. PubMed ID: 6211151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillofemoral bypass for aortoiliac occlusive disease.
    Martin D; Katz SG
    Am J Surg; 2000 Aug; 180(2):100-3. PubMed ID: 11044521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease.
    Onohara T; Komori K; Kume M; Ishida M; Ohta S; Takeuchi K; Matsumoto T; Sugimachi K
    J Cardiovasc Surg (Torino); 2000 Dec; 41(6):905-10. PubMed ID: 11232974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Axillofemoral by-pass as an alternative for amputation in chronic ischemia of the lower limbs].
    Domeniconi R; Mainenti M; Labate C
    Minerva Med; 1973 Dec; 64(90):4721-5. PubMed ID: 4272859
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved patency after axillofemoral bypass for aortoiliac occlusive disease.
    Samson RH; Showalter DP; Lepore MR; Nair DG; Dorsay DA; Morales RE
    J Vasc Surg; 2018 Nov; 68(5):1430-1437. PubMed ID: 29691098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of aortoiliac disease by axillofemoral artery bypass.
    Sheiner NM
    Can J Surg; 1979 Jan; 22(1):19-21. PubMed ID: 156061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillofemoral bypass reconstructions in sixty-one patients with leg ischemia.
    Broomé A; Christenson JT; Eklöf B; Norgren L
    Surgery; 1980 Nov; 88(5):673-6. PubMed ID: 6449089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High recurrence rate following axillofemoral bypass: is continued use still justified?].
    Hepp W; Pallua N
    Zentralbl Chir; 1985; 110(18):1138-46. PubMed ID: 4082804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five- to seven-year experience with externally-supported Dacron prostheses in axillofemoral and femoropopliteal bypass.
    Schultz GA; Sauvage LR; Mathisen SR; Mansfield PB; Smith JC; Davis CC; Hall DG; Rittenhouse EA; Kowalsky TE
    Ann Vasc Surg; 1986 Sep; 1(2):214-24. PubMed ID: 2973796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal.
    Seeger JM; Pretus HA; Welborn MB; Ozaki CK; Flynn TC; Huber TS
    J Vasc Surg; 2000 Sep; 32(3):451-9; discussion 460-1. PubMed ID: 10957651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillofemoral bypass: outcome and hemodynamic results in high-risk patients.
    Schneider JR; McDaniel MD; Walsh DB; Zwolak RM; Cronenwett JL
    J Vasc Surg; 1992 Jun; 15(6):952-62; discussion 962-3. PubMed ID: 1597893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-anatomical grafting for aorto-occlusive disease: the outcome in 133 procedures.
    Schroe H; Nevelsteen A; Suy R
    Acta Chir Belg; 1990; 90(5):240-3. PubMed ID: 2073010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillofemoral bypass graft in a spinal cord injured patient with impending gangrene.
    Lee BY; Guerra J
    J Am Paraplegia Soc; 1994 Oct; 17(4):171-6. PubMed ID: 7869060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortoiliac occlusive vascular disease: a prospective study of patients treated by endarterectomy and bypass procedures.
    Nash T
    Aust N Z J Surg; 1979 Apr; 49(2):223-7. PubMed ID: 157127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.